- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 233/00 - Amides d'acides carboxyliques
Détention brevets de la classe C07C 233/00
Brevets de cette classe: 284
Historique des publications depuis 10 ans
|
9
|
4
|
9
|
13
|
12
|
10
|
7
|
8
|
6
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2706 |
9 |
| Takeda Pharmaceuticals U.S.A., Inc. | 203 |
6 |
| Bristol-myers Squibb Company | 4850 |
5 |
| Ramot at Tel-Aviv University Ltd. | 1490 |
5 |
| Massachusetts Institute of Technology | 10117 |
4 |
| Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 114 |
4 |
| BASF SE | 21039 |
3 |
| Allergan, Inc. | 2334 |
3 |
| Bayer AG | 3364 |
3 |
| FUJIFILM Corporation | 29702 |
3 |
| Abbvie Inc. | 1802 |
3 |
| Council of Scientific & Industrial Research | 1438 |
3 |
| Givaudan SA | 1896 |
3 |
| Les Laboratoires Servier | 536 |
3 |
| Milliken & Company | 1185 |
3 |
| MPC Merger Sub, Inc. | 12 |
3 |
| MPC Oldco, Inc. | 11 |
3 |
| Reata Pharmaceuticals, Inc. | 117 |
3 |
| Tempero Pharmaceuticals, Inc. | 23 |
3 |
| Calico Life Sciences LLC | 100 |
3 |
| Autres propriétaires | 209 |